GSA CAPITAL PARTNERS LLP Kinnate Biopharma Inc. Transaction History

GSA CAPITAL PARTNERS LLP portfolio value:

$876,000
portfolio value

GSA CAPITAL PARTNERS LLP quarter portfolio value change:

-5.23%
quarter

Kinnate Biopharma Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +29.97% 16.89K shares 165K $11.95 73.27K
Q2 2022 share Increase +19.51% 9.20K shares 180K $12.61 56.37K
Q1 2022 share Increase 0.00% 47.17K shares 531K $11.26 47.17K